Latest Strategic Leadership News

Maronan Metals appoints experienced mining executive Andrew Graham as Managing Director and CEO, marking a key leadership transition to advance its Maronan Project through drilling and feasibility milestones.

Regener8 Resources appoints Dave Malesic as Managing Director and CEO, aiming to accelerate its Balkan exploration program and unlock value at the Srebrenica North Project.

LTR Pharma is shifting gears from clinical trials to commercial rollout, securing US partnerships for ROXUS and reporting encouraging SPONTAN Phase II data that supports FDA approval ambitions.

CVC Limited posted a net profit after tax of $7.7 million for FY2026, underpinned by a $37.8 million profit from the Laverton sale and a $13.3 million impairment from the Liverpool project. The company paid a special dividend and restructured leadership amid ongoing capital management efforts.

Aurelia Metals has appointed Steve Badenhorst as its new Managing Director and CEO, effective 6 October 2026, aiming to leverage his 35 years of global mining experience to drive operational performance and strategic growth.

Atomo Diagnostics has appointed Dr Cheri Walker as interim CEO, replacing founder John Kelly who steps down after 15 years. The leadership change aligns with the company's shift towards commercial growth in the US and Europe.

Credit Clear appoints Joshua Reid as Managing Director and interim CEO of ARMA Group Holdings, signaling a leadership shift aligned with its growth ambitions across Australia and international markets.

NZX has appointed seasoned investment executive Hishaam Mirza as its new Chief Executive, aiming to boost the exchange's scale, liquidity, and international relevance.

RPM Automotive's CEO Roy Norris resigned following mutual agreement with the board amid strategic leadership discussions. The company is launching a search for a new CEO and aims to bolster its governance with new independent directors.

WasteCo appoints Brian Cohalan as CEO effective August 31, replacing interim Roger Gower, alongside new regional managers and a COO resignation, signaling a strategic leadership reset.

Fluence Corporation delivered a 14.7% revenue increase in H1 2026, driven by a 34.7% rise in higher-margin Smart Product Solutions and Recurring Revenue, alongside record backlog growth and strategic leadership appointments.

ImpediMed reported a 3% revenue increase to $3.6 million in Q4 FY26, bolstered by a $15.3 million capital raise and strategic leadership hires as it pushes growth in cancer survivorship, heart health, and weight management.